CNBC’s Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them while ...
CNBC’s Jim Cramer previews key earnings reports and investor days that could trigger Wall Street action for the week of ...
HHS houses major health agencies in the U.S., like the FDA, the CDC and the NIH, and it’s also responsible for Medicare and ...
CNBC’s Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year, including Cava, ...
CNBC’s Jim Cramer on Wednesday told investors why Donald Trump’s administration might not be as friendly to big business as ...
Altria Group is "undervalued," Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of ...
CNBC’s Jim Cramer suggested that if Trump’s new tax plans are similar to those he implemented in 2016, wealthy people will ...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Microsoft Corporation MSFT. On Oct. 30, Microsoft ...
Cramer took to X to express his admiration for Salesforce's Agentforce, calling it "pretty revolutionary." He also noted that ...
CNBC's Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year and suggested they were smart investments — although most were also very speculative.
Amgen Inc.'s stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its ...
CNBC's Jim Cramer said the Trump-fueled rally has taken a breather as Wall Street weighs what broad tax cuts could mean for the bond market. "If you believe we're about to get big tax cuts ...